Composition and medical product for reducing body weight and body fat, and use of said product
Abstract
Provided is a plant extract composition and a pharmaceutical composition thereof for reducing body weight and body fat, wherein the plant extract composition comprises a green tea extract and a turmeric extract respectively 30 wt % to 75 wt % and 20 wt % to 55 wt % of a total weight of the composition. In diet-induced obesity models, either obesity is induced first or simultaneously with administration, the plant extract composition and a pharmaceutical composition thereof can reduce body weight and body fat more significantly than a single plant extract or commercially available weight loss drugs.
Claims
exact text as granted — not AI-modified1 - 33 . (canceled)
34 . A composition for reducing body weight or body fat, comprising epigallocatechin gallate (EGCG), curcumin, and a pharmaceutically acceptable excipient.
35 . The composition of claim 34 , wherein the value of the weight ratio between curcumin and EGCG in the composition is 0.32 to 3.2.
36 . The composition of claim 34 , wherein the value of the weight ratio between curcumin and EGCG in the composition is 0.4.
37 . The composition of claim 34 , wherein the value of the weight ratio between curcumin and EGCG in the composition is 3.2.
38 . The composition of claim 34 , wherein the pharmaceutically acceptable excipient comprises polyoxyethylene stearates, piperine, or a combination thereof.
39 . The composition of claim 38 , wherein the polyoxyethylene stearate is polyoxyethylene (32) stearate, polyoxyethylene (40) stearate, or a combination thereof.
40 . The composition of claim 34 , wherein the composition further comprises resveratrol.
41 . The composition of claim 34 , wherein the composition is formulated for oral administration or for injection.
42 . A method for reducing body weight or body fat in a subject, the method comprising administering to a subject in need thereof an effective amount of the composition of claim 34 .
43 . The method of claim 42 , wherein the value of the weight ratio between curcumin and EGCG in the composition is 0.32 to 3.2.
44 . The method of claim 42 , wherein the value of the weight ratio between curcumin and EGCG in the composition is 0.4.
45 . The method of claim 42 , wherein the value of the weight ratio between curcumin and EGCG in the composition is 3.2.
46 . The method of claim 42 , wherein the pharmaceutically acceptable excipient comprises polyoxyethylene stearates, piperine, or a combination thereof.
47 . The method of claim 46 , wherein the polyoxyethylene stearate is polyoxyethylene (32) stearate, polyoxyethylene (40) stearate, or a combination thereof.
48 . The method of claim 42 , wherein the composition further comprises resveratrol.
49 . The method of claim 42 , wherein the composition is administered to the subject orally or by injection.
50 . The method of claim 42 , wherein the subject is a human subject.Join the waitlist — get patent alerts
Track US2020230102A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.